kneat.com, inc. (TSE:KSI - Free Report) - Equities researchers at Cormark increased their FY2024 earnings per share (EPS) estimates for kneat.com in a research report issued on Thursday, November 7th. Cormark analyst G. Fairweather now anticipates that the company will post earnings per share of ($0.08) for the year, up from their prior forecast of ($0.12). The consensus estimate for kneat.com's current full-year earnings is ($0.12) per share. Cormark also issued estimates for kneat.com's FY2025 earnings at ($0.02) EPS and FY2026 earnings at $0.03 EPS.
A number of other research firms have also commented on KSI. Ventum Cap Mkts raised kneat.com to a "strong-buy" rating in a research note on Wednesday, August 7th. CIBC set a C$6.00 price objective on kneat.com and gave the company an "outperform" rating in a research note on Tuesday, October 29th. Finally, Cibc World Mkts raised kneat.com to a "strong-buy" rating in a research note on Tuesday, October 29th.
Read Our Latest Stock Analysis on kneat.com
kneat.com Price Performance
Shares of KSI stock traded down C$0.05 during mid-day trading on Monday, reaching C$5.00. The stock had a trading volume of 40,641 shares, compared to its average volume of 59,115. kneat.com has a 12-month low of C$2.73 and a 12-month high of C$5.17. The company has a market cap of C$430 million, a P/E ratio of -31.56, a price-to-earnings-growth ratio of 597.67 and a beta of 1.08. The business has a 50-day simple moving average of C$4.76 and a 200 day simple moving average of C$4.50. The company has a current ratio of 1.47, a quick ratio of 1.50 and a debt-to-equity ratio of 95.14.
About kneat.com
(
Get Free Report)
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.
Recommended Stories
Before you consider kneat.com, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.
While kneat.com currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
